Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer

Radiation Oncology Investigations

Volumn 6, Issue 5, 1998, Pages 226-232

  Kamath, Sachin S ^a   McCarley, Dean L ^a   Zlotecki, Robert A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Combined modality therapy; Metastasis; Radiotherapy; Small cell lung carcinoma survival rate

Indexed keywords

ETOPOSIDE; PLATINUM;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; METASTASIS; PRIORITY JOURNAL; PROPHYLAXIS; SKULL IRRADIATION;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATINUM COMPOUNDS; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031770463     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:5<226::AID-ROI4>3.0.CO;2-H     Document Type: Article

References (20)

1. Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al.: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327(23): 1618-1624, 1992.
2. Warde P, Payne D: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10(6):890-895, 1992.
3. Arriagada R, Le-Chevalier T, Borie F, Riviere A, Chomy P, Monnet I, Tardivon A, Viader F, Tarayre M, Benhamou S: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87(3):183-190, 1995.
4. Aroney RS, Aisner J, Wesley MN, Whitacre MY, Van-Echo DA, Slawson RG, Wiemik PH: Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat Rep 67(7-8): 675-682, 1983.
5. Liengswangwong V, Bonner JA, Shaw EG, Foote RL, Frytak S, Richardson RL, Creagan ET, Eagan RT, Su JQ: Prophylactic cranial irradiation in limited-stage small cell lung cancer. Cancer 75(6):1302-1309, 1995.
6. Ohonoshi T, Ueoka H, Kawahara S, Kiura K, Kamei H, Hiraki Y, Segawa Y, Hiraki S, Kimura I: Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: a long-term follow-up result. Lung Cancer 10(1-2):47-54, 1993.
7. Rosen ST, Makuch RW, Lichter AS, Ihde DC, Matthews MJ, Minna JD, Glatstein E, Bunn PA, Jr. Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response. Am J Med 74(4):615-624, 1983.
8. Rosenstein M, Armstrong J, Kris M, Shank B, Scher H, Fass D, Harrison L, Fuks Z, Leibel S: A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer. Int J Radiat Oncol Biol Phys 24(1):43-48, 1992.
9. Seydel HG, Creech R, Pagano M, Salazar O, Rubin P, Concannon J, Carbone P, Mohiuddin M, Perez C, Matthews M: Prophylactic versus no brain irradiation in regional small cell lung carcinoma. Am J Clin Oncol 8(3):218-223, 1985.
10. American Joint Committee on Cancer: Manual for Staging of Cancer, 2nd ed. Philadelphia: J.B. Lippincott Company, 1983.
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
12. SAS Institute Inc. SAS Technical Report P-179, Additional SAS/STAT Procedures, Release 6.03 ed. Cary, NC: SAS Institute Inc., 1988.
13. Lawless JF: Statistical Models and Methods for Lifetime Data. New York: Wiley, 1982.
14. Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, Payne D, Kostashuk EC, Evans WK, Dixon P: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 11(2):336-344, 1993.
15. Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ: Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 31(4):807-811, 1995.
16. Arriagada R, Le-Chevalier T, Ruffle P, Baldeyrou P, De Cremoux H, Martin M, Chomy P, Cerrina ML, Pellae-Cosset B, Tarayre M, Sancho-Garnier H: Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited cell lung carcinoma. Int J Radiat Oncol Biol Phys 19:1135-1138, 1990.
17. Choi MC, Carey RC: Locoregional failure rate in relation with radiation dose in combined modality approach of multi-agent chemotherapy and radiotherapy for limited-stage small cell lung carcinoma. [Abstract] Int J Radiat Oncol Biol Phys 13(Suppl. 1):188-189, 1987.
18. Johnson BE, Salem C, Nesbitt J, Gazdar AF, Lesar M, Phelps R, Edison M, Linnoila RI, Phares J, Pass H, Mulshine JL, Minna JD, et al.: Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer 9(Suppl. 1):S21-S26, 1993.
19. Turrisi AT, Glover DJ, Mason B, Tester W: Long term results of platinum etoposide (PE) + twice daily (BID) thoracic radiotherapy (TRT) for limited small-cell lung cancer (LSCLC): Results on 32 patients with 48 month minimum F/U. [Abstract] Proc Annu Meet Am Soc Clin Oncol 11:292, 1992.
20. Shaw EG, Su JQ, Eagan RT, Jett JR, Maksymiuk AW, Deigert FA: Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. J Clin Oncol 12(11):2327-2332, 1994.